Investigation of the histology and interfacial bonding between carbonated hydroxyapatite cement and bone.
An ideal bone implant should facilitate the formation of a new bone layer as an osteo-integrated interface between bone and the implanted biomaterials. In the present work, the interface between carbonated hydroxyapatite (CHA) cement and bone was evaluated by interfacial bonding strength measurements and histological characterizations. CHA cement was implanted into a mongrel dog's femoral supracondylar and below the tibial plateau area, and was then tested ex vivo by, respectively, detaching and pullout experiments. Polymethylmethacrylate (PMMA) was used as a control. CHA cement could be directly injected and solidified in situ to repair bone defects. Histology results showed that CHA bonded with bone through gradual remodeling and was replaced by new bone tissue, which is an attribute for excellent biocompatibility. The interfacial bonding strength increased with implantation time. After 16 weeks implantation, the measured detaching force and the pullout force between CHA and bone were 281 +/- 16 N and 512.5 +/- 14.5 N, respectively. These values were several times higher compared to 5 days implantation. In contrast, the control showed a fibrous microstructure between PMMA and bone, and the detaching force and the pullout force decreased with implantation time. The results strongly suggest that CHA can form a better osteo-integrated interface compared to PMMA, and could be used as an ideal biomaterial for bone defect repair.
Mao
Keya
K
Department of Orthopedics, General Hospital of People's Liberation Army, 28 Fuxing Road, Beijing 100853, People's Republic of China.
Yang
Yun
Y
Li
Jiangtao
J
Hao
Libo
L
Tang
Peifu
P
Wang
Zheng
Z
Wen
Ning
N
Du
Mingkui
M
Wang
Jifang
J
Wang
Yan
Y
D000818:Animals; D001672:Biocompatible Materials / Q000737:chemistry*; D001842:Bone and Bones / Q000473:pathology* / Q000648:ultrastructure; D002254:Carbonates; D004285:Dogs; D017886:Durapatite; D005269:Femur / Q000503:physiopathology*; D006882:Hydroxyapatites; D008297:Male; D019904:Polymethyl Methacrylate / Q000737:chemistry* / Q000627:therapeutic use*; D019736:Prostheses and Implants; D013977:Tibia / Q000737:chemistry* / Q000378:metabolism / Q000648:ultrastructure
D001672:Biocompatible Materials; D002254:Carbonates; D006882:Hydroxyapatites; C475044:hydroxyapatite cement; D019904:Polymethyl Methacrylate; D017886:Durapatite